Leitung
Prof. Dr. Carsten Watzl
Sekretariat
Doris Teutsch
Anschrift
Ardeystr. 67
44139 Dortmund

Publikationen Immunologie

Catecholamines and immunomodulation. In: Konsman JP, Reyes TM (eds): Neuroendocrine-immune system interactions (pp 105-133). Cham: Springer, 2023 (Masterclass in Neuroendocrinology, Vol. 13)
Impact of low eGFR on the immune response against COVID-19. J Nephrol 36: 199–202 (2023)
A modelling framework for local thermal comfort assessment related to bicycle helmet use. J Thermal Biol 112: 103457 (2023)
14th Conference of the German Endocrine-Brain-Immune-Network (GEBIN), Erlangen, March 30 – April 1, 2022. Abstracts. Basel: Karger, 2022 (Neuroimmunomodulation, Vol. 29, Suppl. 1)
In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant. Front Immunol 13: 1062210 (2022) (14 pp)
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV. Front Immunol 13: 1049070 (2022) (13 pp)
Impact of N6-methyladenosine (m6A) modification on immunity. Cell Commun Signal 20 (1): 140 (2022) (12 pp)
Inhibition of glucose uptake blocks proliferation but not cytotoxic activity of NK cells. Cells 11: 3489 (2022) (18 pp)
Calibrating a comprehensive immune age metric to analyze the cross sectional age-related decline in cardiorespiratory fitness. Biology 11: 1576 (2022) (14 pp)
Distinct distribution patterns of exercise-induced natural killer cell mobilization into the circulation and tumor tissue of patients with prostate cancer. Am J Physiol Cell Physiol 323: C879–C884 (2022)
How COVID-19 pandemic influenced air quality in Polish cities – lessons from three lockdowns. Geogr Pol 95: 255-274 (2022)
Indicators to assess physiological heat strain – Part 2: Delphi exercise. Temperature 9: 263-273 (2022)
Indicators to assess physiological heat strain – Part 1: Systematic review. Temperature 9: 227-262 (2022)
Human NK cells responses are enhanced by CD56 engagement. Eur J Immunol 52: 1441-1451 (2022)
Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination. Front Immunol 13: 980526 (2022) (13 pp)